With regard to the government's $173 million funding for Medicago announced in 2020: (a) does the government or the Mitsubishi Chemical Group own the intellectual property developed as a result of this funding; (b) what measures, if any, did the government take to ensure that the intellectual property developed from the funding would remain in Canada; (c) did the government receive any long-term job commitments from Medicago or Mitsubishi Chemical Group in return for the $173 million, and, if so, what are the details of such commitments; and (d) did the government receive value for money in exchange for the $173 million, and, if not, what corrective action is being taken?
In the House of Commons on March 27th, 2023. See this statement in context.